CTL Amedica was granted a U.S. patent (No. 10,543,101) addressing a screw offset blocking mechanism, designed for and implemented in the company’s MONET™ Anterior Cervical Fusion System, available in titanium and PEEK cage options. The company plans to apply the technology in future cervical and lumbar plating products.
“Cervical surgeries make up more than half of all spine surgeries worldwide, and integrated technologies continue to flourish throughout the entire orthopedic implant sector, so we’re particularly pleased to announce this new patent. The blocking technology can be utilized in current and future products and may have licensing possibilities down the road,” said Daniel Chon, CTL Amedica’s President and CEO. “Due to its fundamental application throughout the entire orthopedic fixation arena, screw blocking technology is one of the most competitive and intellectually protected areas of medical device development today. CTL Amedica’s newly patented technology is one of many core development investments our company is making.”
CTL Amedica was granted a U.S. patent (No. 10,543,101) addressing a screw offset blocking mechanism, designed for and implemented in the company’s MONET™ Anterior Cervical Fusion System, available in titanium and PEEK cage options. The company plans to apply the technology in future cervical and lumbar plating products.
CTL Amedica was granted a U.S. patent (No. 10,543,101) addressing a screw offset blocking mechanism, designed for and implemented in the company’s MONET™ Anterior Cervical Fusion System, available in titanium and PEEK cage options. The company plans to apply the technology in future cervical and lumbar plating products.
“Cervical surgeries make up more than half of all spine surgeries worldwide, and integrated technologies continue to flourish throughout the entire orthopedic implant sector, so we’re particularly pleased to announce this new patent. The blocking technology can be utilized in current and future products and may have licensing possibilities down the road,” said Daniel Chon, CTL Amedica’s President and CEO. “Due to its fundamental application throughout the entire orthopedic fixation arena, screw blocking technology is one of the most competitive and intellectually protected areas of medical device development today. CTL Amedica’s newly patented technology is one of many core development investments our company is making.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
